Find doctors, physicians, and healthcare providers who prescribe Alendronate Sodium in Utah. This page lists the top prescribers of Alendronate Sodium based on Medicare Part D data, including the number of claims, patients served, and total drug costs.
What is Alendronate Sodium?
BINOSTO is a bisphosphonate indicated for: Treatment of osteoporosis in postmenopausal women ( 1.1 ) Treatment to increase bone mass in men with osteoporosis ( 1.2 ) Limitation of use: Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use ( 1.3 ) 1.
Total Claims in Utah
57,702
0.8% of all Alendronate Sodium prescriptions nationwide
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services. Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.